Chemotherapy for dogs – yes or no? Quality of life and decision

The most important answer first

After a cancer diagnosis, dog owners often immediately ask: "Should I subject my dog to chemotherapy?" The very phrasing reveals the extent of their concern. Many people think of distressing experiences in human medicine, such as severe nausea, hair loss, weakness, and lengthy hospital stays. However, chemotherapy in dogs generally pursues a different, practical goal: to control the tumor without disproportionately impacting the dog's quality of life.

The correct answer is therefore neither a simple "yes" nor a simple "no." Chemotherapy in dogs is advisable when there is a realistic chance of giving the dog more quality of life, fewer tumor-related symptoms, or a longer period of stable illness. It is less advisable when the expected effect is minimal, the dog is already severely weakened, or the burden of treatment, examinations, and side effects outweighs the potential benefits.

The current American Animal Hospital Association Oncology Guidelines They explicitly state that maintaining the best possible quality of life is the central goal of chemotherapy in veterinary medicine. Most veterinary protocols are well tolerated. Approximately 15 to 30 percent of treated dogs develop side effects, which are predominantly mild and treatable. Severe or potentially life-threatening complications are reported in approximately five to seven percent of cases, depending on the patient, medication, and protocol. These figures should not be downplayed, but they also demonstrate that chemotherapy in dogs is not automatically associated with permanent suffering.

In my veterinary experience, the decision is particularly sound when it is not solely based on fear or hope. It should be based on five points: the exact type of tumor, the stage of the disease, the expected effects, the dog's physical and emotional resilience, and the resources of its family.

What chemotherapy can actually achieve in dogs

The term "chemotherapy" encompasses various medications and treatment approaches. Some preparations are administered as an infusion, others as an injection or tablet. A single active ingredient or a combination of several medications may be used. In addition, there are low-dose metronomic treatments and targeted therapies such as certain tyrosine kinase inhibitors. Not every oral cancer medication is a classic chemotherapy, but the necessary monitoring and safety precautions for dog owners are often similar.

Chemotherapy in dogs can have different goals:

Remission: The tumor or measurable signs of disease are significantly reduced. Complete remission means that there are currently no clinically detectable signs of disease. It does not automatically mean that all tumor cells have been permanently eliminated.

Adjuvant treatment: For example, the visible tumor was surgically removed, but due to its biological properties, there is a high risk of microscopic metastases. Chemotherapy in the dog is then intended to combat any remaining tumor cells or delay the formation of visible metastases.

Palliative treatment: A cure is no longer realistic. The treatment aims to slow tumor growth, alleviate symptoms, and buy as much time as possible.

Permanent cure: While it is possible in some tumor diseases and multimodal treatment approaches, it is not the most likely goal in many systemic canine cancers. Often, the focus is on control, remission, or slowing the progression of the disease.

The distinction between local and systemic diseases is particularly important. A clearly defined skin tumor can sometimes be treated with complete surgery. In contrast, lymphoma usually affects the lymphatic system and thus the entire body. In this case, systemic chemotherapy is often the most important treatment option for dogs. The Merck Veterinary Manual describes high initial response rates for certain common forms of canine lymphoma. However, the actual outcome depends on factors such as cell type, tumor grade, stage, general health, and the chosen protocol.

The effect can be significantly more limited in other tumors. For example, in the case of splenic hemangiosarcoma, Cornell University reports median survival times of approximately four to six months after surgery and subsequent chemotherapy, whereas after surgery alone, the median survival is often around two months. This is a possible, but limited, gain in time. For the individual dog, the course of the disease can be shorter or considerably longer.

In cases of appendicular osteosarcoma, chemotherapy following amputation or limb-sparing treatment can increase the median life expectancy to approximately one year, according to the University of California, Davis. However, even in these cases, there is no guarantee. These examples illustrate why the question of chemotherapy in dogs must always be addressed in conjunction with a specific tumor diagnosis.

First the diagnosis, then the decision

Chemotherapy in dogs should generally not be started solely on the suspicion of cancer. Before making a decision, it is essential to determine the exact type of tumor. Depending on the disease, a cytological examination of cells, for example from an enlarged lymph node, may suffice. In other cases, a tissue sample with histopathological examination is required.

The pathological findings can answer important questions:

• What type of tumor is present?
• Is it a low-grade or high-grade tumor?
• How aggressive does the cell image appear?
• Was the surgically removed tumor completely?
• Are there any particular biological characteristics that influence the treatment?

Following this, insofar as it is relevant to the specific decision, the so-called staging process takes place. This involves examining how far the disease has spread. Depending on the type of tumor, blood tests, organ function tests, urinalysis, chest X-rays, abdominal ultrasound, computed tomography (CT) scans, examination of regional lymph nodes, or other samples may be useful. The AAHA guidelines emphasize that a cytological or histopathological diagnosis, and for many tumors, the determination of the stage or grade, are necessary for a reliable prognosis.

Not every theoretically possible test changes the therapy. Therefore, before every test, the question should be asked: "Would the result change our decision?" A test that does not influence the treatment protocol, the assessment of quality of life, or the prognosis may be unnecessary. Conversely, incomplete staging can lead to unrealistic expectations.

Before a dog undergoes chemotherapy, owners should receive understandable answers to the following questions:

1. How certain is the diagnosis?
2. What is the treatment goal?
3. How likely is a measurable response?
4. What period of time with a good quality of life is realistic with and without treatment?
5. How often are appointments, blood tests, and possible emergency visits required?
6. What side effects can be expected with this specific medication?
7. Under what conditions will the therapy be adjusted or discontinued?

A responsible veterinarian will not give an exact "remaining lifespan." Statistical values describe groups of patients, not the fate of an individual dog. Even an experienced oncologist cannot reliably predict the individual course of the disease. Therefore, a reliable approach is to provide a range of values, along with an explanation of the favorable and unfavorable influencing factors.

When chemotherapy is more appropriate for dogs

Chemotherapy in dogs is primarily indicated in cases of tumor disease where its benefit is well-established through clinical experience and scientific data. This applies, for example, to many lymphomas, certain leukemias, as well as selected sarcomas, carcinomas, and mast cell tumors. Chemotherapy can also be beneficial after surgery if the primary tumor has been removed but there is a significant risk of metastasis.

Another important point is the dog's current general condition. A dog that eats, shows interest in its surroundings, enjoys exercise, and whose organ functions are sufficiently stable usually has a better chance of success than a patient with pronounced weakness, severe anemia, uncontrollable pain, or concurrent organ failure. Age should not be equated with illness. A fit twelve-year-old dog may be a more suitable candidate than a significantly younger dog with serious underlying health conditions.

Chemotherapy in dogs is more justifiable if the expected outcome justifies the treatment effort. A realistic prospect of many months of good quality of life can justify multiple appointments and blood tests. However, if there is only a very small chance of a few additional weeks of life, the burden must be carefully considered.

The dog's behavior is also part of the medical assessment. Some dogs enter the veterinary practice relaxed, allow themselves to be examined without any problems, and tolerate an intravenous catheter well. Others experience the journey and the waiting room as a major ordeal. For a highly anxious dog, a protocol that seems effective on paper may be less practical in real-life situations. In such cases, calm scheduling, waiting time in the car, stress-free handling, or veterinarian-prescribed anti-anxiety medication may be helpful.

When a no or limited treatment might be reasonable

Intensive chemotherapy in dogs may be contraindicated if the tumor is likely to respond poorly to available medications. A very advanced stage of the disease with severe, uncontrollable symptoms can also limit the potential benefit. The crucial factor is not simply whether further treatment is technically possible, but whether the treatment is likely to help the dog.

Serious comorbidities can increase the risk or limit the choice of medications. For certain drugs, for example, cardiac, hepatic, renal, and bone marrow function must be given particular consideration. Doxorubicin can be problematic in dogs with impaired cardiac function, while other medications each have their own organ-specific risks. Such risks do not automatically preclude all chemotherapy in dogs, but they may necessitate an adapted protocol or a different treatment strategy.

A "no" can also be the right answer if the dog is subjected to exceptional stress due to repeated journeys, restraint, and examinations. The owner's resources are also relevant. Time commitment, distance to the treatment clinic, care for other family members, and financial limitations should all be discussed honestly. Financial constraints are not a sign of a lack of love for the animal. Therapy that is consistently overwhelming for the owner is often not sustainable for the dog either.

Choosing not to use chemotherapy in a dog does not mean doing nothing. Pain management, anti-nausea medication, supportive feeding, treatment of inflammation, palliative radiation, relieving surgery, or targeted end-of-life care can all be active and responsible medicine. Cornell explicitly points out that palliative measures can alleviate pain, inflammation, and nausea when tumor-specific treatment is not pursued.

Quality of life is more than eating and going for walks

When deciding on chemotherapy for a dog, it's often said: "As long as he's eating, he's doing well." Food intake is important, but it's not sufficient as the sole criterion. Some dogs eat despite pain or shortness of breath. Others skip a meal due to mild nausea, but are otherwise alert and interested.

Quality of life should therefore be systematically monitored. In my view, the following areas are particularly relevant:

Observation area	Questions for everyday life
Appetite and nausea	Is the dog eating willingly? Is he turning away from the food? Is he smacking his lips, drooling, or gagging?
Pain and rest	Can he lie down and sleep comfortably? Does he pant without warmth or exertion?
Movement	Does he get up on his own? Does he enjoy walking short distances?
interest	Does he greet familiar people? Does he react to smells, play, or environmental stimuli?
breathing	Does he breathe evenly and without visible effort when at rest?
Digestion and hygiene	Are there any symptoms of vomiting, diarrhea, urinary problems, or soiling?
Good days and bad days	Do the noticeably good days outweigh the good days in a given week?

Before starting chemotherapy in a dog, it's helpful to document the initial condition for a few days. This makes it easier to distinguish later whether a change is caused by the tumor, the treatment, or another illness. A short diary with a rating of zero to two points per area is often sufficient. Photos and short videos can also help to detect gradual changes.

Before the first dose, personal discontinuation or adjustment criteria should be discussed. A possible plan could be: The treatment will be reviewed if the dog does not eat for more than a day, vomits repeatedly, develops persistent diarrhea, is feverish or unusually lethargic, if pain cannot be adequately controlled, or if several bad days occur in a row. The specific limits must be tailored to the individual patient and the protocol.

It is important to distinguish between a short-term, easily treatable side effect and a lasting loss of quality of life. Two days of mild fatigue may be acceptable if several good weeks follow. However, repeated severe crises, hospitalizations, and long recovery periods may be reasons to reduce the dose, change the medication, or discontinue chemotherapy in the dog.

Regular follow-up examinations are not only for assessing tumor size and blood values. They should also document pain, nutrition, comorbidities, potential long-term effects, and the dog's actual daily life. The AAHA recommends follow-up care tailored to the tumor type, stage, and protocol, and emphasizes the ongoing evaluation of quality of life.

Realistically assessing the side effects of chemotherapy in dogs

The most common side effects affect the gastrointestinal tract and bone marrow. Possible side effects include nausea, decreased appetite, vomiting, diarrhea, fatigue, and a temporary decrease in certain blood cells. According to AAHA guidelines, gastrointestinal symptoms are usually self-limiting and last on average about three days. Preventive or early administration of anti-nausea medication can significantly reduce the burden.

A dog can show signs of nausea without vomiting. Possible indicators include smacking of the lips, increased salivation, frequent swallowing, restlessness, grass eating, showing interest in food followed by turning away, or avoiding food offered shortly after treatment. Such observations should be reported promptly. A quick adjustment of any accompanying medication can prevent loss of appetite and weight loss.

Bone marrow suppression particularly affects neutrophils, which are crucial for fighting bacterial infections. The lowest neutrophil count is called the nadir. For many medications, it occurs approximately one week after treatment, but depending on the specific drug, it can appear earlier or considerably later. If there is a corresponding risk, a blood count is performed at this time. Febrile neutropenia, the combination of fever and a low neutrophil count, is an oncological emergency and usually requires inpatient treatment with fluids and intravenous antibiotics.

Immediate contact with the treating veterinary practice or the emergency veterinary service is required in the following cases:

• pronounced apathy or weakness,
• repeated vomiting,
• severe or bloody diarrhea,
• complete refusal to eat,
• noticeable shortness of breath,
• Collapse,
• Bleeding,
• Fever or a marked feeling of illness,
• Pain or swelling at the infusion site,
• Problems with urination.

Dog owners should not give their dogs medications from their own medicine cabinet. Many human medications, including certain painkillers, can be dangerous for dogs or interact with cancer therapy.

Extensive hair loss is much less common in dogs than in humans. However, breeds with continuously growing coats, such as poodles, can develop visible coat changes. Altered coat texture or a slower growth rate are also possible. The AAHA lists poodles, Scottish Terriers, and West Highland White Terriers as breeds at higher risk.

In addition, there are drug-specific risks. Doxorubicin can damage the heart and cause severe tissue reactions if it leaks from the vein. Cyclophosphamide can trigger sterile, bloody cystitis. Lomustine can, among other things, affect the liver and bone marrow. These examples show why one shouldn't speak generally about "the side effects of chemotherapy." The specific drug, the dose, the combination, and the dog's initial health status are always crucial.

This is how chemotherapy typically proceeds in dogs.

The dog undergoes a physical examination before every treatment. Depending on the protocol, weight, temperature, mucous membrane color, lymph nodes, heart, and circulation are checked. A blood test is often required. For certain medications, organ function tests, urinalysis, blood pressure measurements, echocardiograms, or other examinations may be added.

The dose is usually calculated based on body surface area or body weight and adjusted as needed. A dose reduction is not a treatment failure. It may be necessary if the dog experienced severe side effects at the previous appointment or if the blood cells have not recovered sufficiently. The goal is not to impose a predetermined plan regardless of the patient. The plan must be tailored to the patient.

Intravenous medications are administered via a securely positioned venous catheter. Some drugs can severely damage tissue if they leak outside the vein. Therefore, calm and secure restraint is an important part of the treatment. For very restless or anxious dogs, it is essential to determine beforehand how stress and movement can be reduced.

After administration, the owner receives detailed instructions regarding possible side effects, emergency signs, feeding, and safety precautions. Written information about when symptoms typically occur and a telephone number to reach outside of office hours is also helpful.

Safety at home after chemotherapy for dogs

After chemotherapy, small amounts of medication may be excreted in urine, feces, vomit, or other bodily fluids. The timeframe depends on the specific drug. Special precautions are often necessary, at least during the first 72 hours; some medications may require longer periods. Therefore, always refer to the written instructions provided by your doctor's office.

The Veterinary Cancer Society Among other things, it recommends wearing chemotherapy-safe disposable gloves when handling urine, feces, or vomit, thorough handwashing, and double-packaging contaminated waste. Young children, pregnant women, breastfeeding women, people trying to conceive, and people with weakened immune systems should not handle cancer medications or contaminated bodily fluids.

Tablets or capsules must be stored in their original container and out of the reach of children and animals. They must not be divided, crushed, opened, or dissolved in water unless specifically instructed to do so by the treating veterinary practice and with appropriate protective measures in place. The recommended gloves must be worn when administering the medication. If the dog vomits shortly after oral chemotherapy, do not administer a second dose yourself. The veterinary practice must decide whether and when to administer another dose.

Normal physical contact and affection are still possible. The dog does not need to be socially isolated. However, direct contact with bodily fluids and excessive licking of the face or hands should be avoided during the aforementioned safety period.

Nutrition during treatment

A general "cancer diet" is not necessary for successful chemotherapy in dogs. The most important goal is to maintain weight and muscle mass as stable as possible and to offer a completely balanced, well-tolerated diet. A dog that enjoys and tolerates its usual food well will not automatically benefit from a sudden change.

Raw feeding is problematic during periods of potential immunosuppression because pathogens from raw meat can pose an increased risk to patients with low immune cells. Cornell University advises against raw feeding for animals undergoing cancer treatment and recommends avoiding unnecessary, abrupt dietary changes. Changes, if necessary, should be made slowly and in consultation with a veterinarian.

If a dog is eating less, the first steps should be to check for nausea, pain, mouth problems, constipation, tumor progression, or side effects. Simply offering particularly palatable food without addressing the underlying cause is often insufficient. Medication for nausea, pain relief, appetite stimulants, or targeted nutritional advice may be necessary.

A practical decision-making aid for dog owners

Before starting chemotherapy in a dog, I recommend a joint consultation with clear, written goals. Three plans can be helpful in this process.

Plan A describes the desired course of action. What effect do we expect? After what period will the response be assessed? How many appointments are planned? What minimum quality of life should be maintained?

Plan B describes adjustments. What happens in case of nausea, low blood counts, or severe stress? Can the dose be reduced, the interval extended, or a medication changed? What other medications are available?

Plan C describes the border. When do we stop chemotherapy for the dog and switch to purely palliative care? Which symptoms would no longer be acceptable? How will the dog be cared for if the disease progresses despite treatment?

A limited trial period can be useful in selected situations. This doesn't mean simply "starting without careful consideration," but rather that a timeframe for evaluating tolerability and effectiveness is established beforehand. It's important that discontinuation remains an option. Deciding to begin therapy is not a contract to continue treatment under all circumstances.

The following constellations speak more for or against the beginning:

This speaks more in favor of the treatment.	Requires particularly critical examination
A tumor type that responds well	Expected low effectiveness
Good overall condition	Severe weakness or uncontrollable symptoms
Relevant prospect of good additional time	Very small expected benefit
Well-controlled comorbidities	Severe heart, liver, kidney or bone marrow disease
Dog tolerates rides and examinations	Severe panic and almost irreducible treatment stress
Reliable emergency and care plan	Checks or emergency care practically impossible
Clear termination criteria	Unclear goals and unrealistic expectations

No single point in the table is the sole deciding factor. A dog can benefit from palliative chemotherapy despite advanced disease. Conversely, even with a fundamentally treatable tumor, chemotherapy may be ruled out if the individual burden would be too great.

Palliative care is an active treatment

If chemotherapy is not administered to the dog or is discontinued, a specific palliative care plan should be implemented. Depending on the illness, this may include pain medication, anti-nausea drugs, appetite and digestive support, treatment of respiratory distress, adjustments to movement, assistance with getting up, and regular check-ups.

In some tumors, palliative radiation therapy can reduce pain. Surgery may be beneficial if it prevents bleeding, pressure, bowel obstruction, or other local complications. Corticosteroids can alleviate symptoms in certain conditions, but should not be started independently or without prior diagnostic evaluation.

Palliative care also includes discussing the end of life early on. This is not about giving up, but about planning ahead. The owner should know what changes indicate a crisis, who to reach at night or on weekends, and under what conditions euthanasia would protect the dog from uncontrollable suffering.

Cornell University describes quality of life as the most important criterion in difficult cancer decisions. Personality, stress associated with travel, comorbidities, and family resources should explicitly be considered in the decision-making process.

My veterinary recommendation

Chemotherapy for dogs should not be rejected prematurely out of fear, nor should it be started out of guilt. Demand a clear diagnosis, a realistic treatment goal, and an understandable comparison of treatment and palliative care.

For complex tumor diseases, consultation with a veterinarian specializing in oncology is advisable. Such a consultation does not obligate the veterinarian to treat the disease. It may also lead to the conclusion that surgery, radiation therapy, tailored drug therapy, or purely palliative care is the better option. The Veterinary Cancer Society emphasizes the benefits of specialized oncological consultation for assessing diagnosis, treatment options, and risks.

From my many years of working with small animal patients, I know how difficult this decision can be for a family. Medical data provides guidance, but it doesn't know your dog's personality. You know whether he handles vet visits calmly, what activities he enjoys, and what changes are unusual for him. The best decision comes when veterinary knowledge and this precise knowledge of your own dog are combined.

A responsible decision can be "yes." It can be "yes, but with clear oversight at first." And it can be just as responsible: "no, we'll focus on comfort and quality time together.".

Reputable international sources for further information

• 2026 AAHA Oncology Guidelines for Dogs and Cats
• Cornell University: Cancer Management Frequently Asked Questions
• Cornell University: Difficult Decisions
• Veterinary Cancer Society: Chemotherapy Safety
• Merck Veterinary Manual: Cancer Treatment in Animals

Frequently asked questions about chemotherapy in dogs

Detailed summary: Making responsible decisions about chemotherapy in dogs

The Chemotherapy in dogs is not an automatic consequence of every cancer diagnosis. Whether a Chemotherapy in dogs Whether it is advisable depends on the exact type of tumor, the stage of the disease, the patient's general health, and the expected benefit. Chemotherapy in dogs Treatment should not be started alone, because medical treatment is still possible. The crucial factor is whether the Chemotherapy in dogs This is expected to allow for more good life expectancy, fewer tumor-related symptoms, or a significant delay in disease progression. The goal is not maximum treatment at any cost, but rather the best possible balance between life expectancy and quality of life.

Before a Chemotherapy in dogs A reliable diagnosis is established. Cytology or histopathology should clarify which tumor is present and how aggressive it is. For many diseases, staging is also necessary. Only when the extent, tumor grade, and possible accompanying diseases are known can the Chemotherapy in dogs Plan effectively. Without this information, the effects and risks of a Chemotherapy in dogs They can easily be overestimated or underestimated. Not every tumor is equally sensitive, and not every visible lump requires systemic treatment.

The Chemotherapy in dogs Treatment may be aimed at remission, delaying metastasis, or palliative tumor control. In some lymphomas, the Chemotherapy in dogs A central treatment is necessary because the disease affects the entire body. For other tumors, the Chemotherapy in dogs Surgery or radiation therapy may be used. In aggressive diseases like hemangiosarcoma, the statistical time gain may be limited. Therefore, pet owners need to know whether treatment aims for a cure, a temporary remission, or simply a slower progression.

The side effects of a Chemotherapy in dogs These protocols are not comparable to every course of treatment in human medicine. Most veterinary protocols are planned with a focus on quality of life. Nevertheless, a Chemotherapy in dogs Never completely risk-free. Approximately 15 to 30 percent of dogs develop mostly mild and treatable symptoms. Serious complications are significantly less common, but possible. Before each Chemotherapy in dogs Therefore, expected symptoms, emergency signs, and available contact persons must be clearly discussed.

Common accompanying symptoms of Chemotherapy in dogs These include nausea, loss of appetite, vomiting, diarrhea, and fatigue. Another possible consequence of Chemotherapy in dogs This is the temporary suppression of bone marrow function. If the number of neutrophils drops sharply and the dog develops a fever, it is an emergency. Therefore, monitoring the blood count is an important component of many protocols. Chemotherapy in dogs. The timing and extent of the checks depend on the medication used and the patient's response.

Quality of life must be maintained during the Chemotherapy in dogs They must be continuously assessed. Food intake alone is not enough. Movement, sleep, pain, breathing, interest in familiar people, digestion, hygiene, and the ratio of good to bad days should also be included in the evaluation. A diary records changes during the Chemotherapy in dogs more visible. If symptoms are detected early, accompanying medications, dosage, or intervals can be adjusted. If the quality of life remains poor despite adjustments, the Chemotherapy in dogs to be fundamentally re-evaluated.

The dog's personality also influences the decision about a Chemotherapy in dogs. A relaxed patient who copes well with journeys and examinations has different requirements than a dog with pronounced anxiety about the veterinary clinic. Chemotherapy in dogs This includes not only the effects of the medication, but also travel, waiting times, blood tests, and repeated examinations. Time, care, distance to the clinic, and financial resources must also be considered. Chemotherapy in dogs It is only sustainable in the long term if the entire process can be managed by both dog and owner.

After a Chemotherapy in dogs Safety precautions are necessary in the household. Medication residues can be excreted through urine, feces, and vomit. When disposing of them, appropriate gloves should be worn, and the instructions of the treating physician should be followed. If the Chemotherapy in dogs Administered as a tablet, preparations must not be divided, opened, or crushed without explicit veterinary instructions. Pregnant women, breastfeeding women, young children, and immunocompromised individuals should not handle medications or contaminated excretions. The safety period after the Chemotherapy in dogs depends on the specific active ingredient.

A no to Chemotherapy in dogs This is not the same as neglecting care. Pain management, anti-nausea medication, nutritional support, palliative radiation therapy, relieving procedures, and planned end-of-life care can be medically very valuable. Conversely, a treatment that has been started must be discontinued. Chemotherapy in dogs Treatment should not be continued at all costs. Dose reduction, switching medications, or discontinuation are possible if the benefits and risks are no longer in the desired balance. The decision for or against a Chemotherapy in dogs It should therefore always remain verifiable.

The best decision is made through open communication between the owner, their veterinarian, and, if necessary, a specialized oncologist. Before a Chemotherapy in dogs The diagnosis, treatment goal, expected effect, monitoring, side effects, and costs should be presented transparently. During a Chemotherapy in dogs Effectiveness and quality of life should be regularly reassessed. A responsible Chemotherapy in dogs It is not based solely on lab results or tumor size, but on the patient as a whole. It is appropriate when the dog can not only live longer, but is also likely to live a good life.

Electrochemotherapy for dogs in Karlsruhe and surrounding areas

For dog owners from Karlsruhe, Durlach, Ettlingen, Pforzheim and the surrounding area, the following is also possible: Electrochemotherapy in dogs This could be a possible treatment option. At our Arndt Small Animal Clinic in Karlsruhe-Durlach, we individually assess whether this locally acting procedure is suitable for the specific tumor. A chemotherapeutic agent is combined with short electrical pulses to improve the drug's penetration into the tumor cells. This method is particularly suitable for certain superficial, easily accessible, or incompletely removable tumors, but it does not always replace surgery or conventional chemotherapy. Further information can be found at [website address - please insert here]. Electrochemotherapy for dogs in Karlsruhe.

Professional perspective: Veterinarian Susanne Arndt is the medical director and owner of small animal practices in Karlsbad-Ittersbach and Karlsbad-Langensteinbach. She studied at the Faculty of Veterinary Medicine at the University of Leipzig, worked for six years as an assistant veterinarian at the Dr. Thomas Graf Small Animal Clinic in Cologne, and subsequently established and expanded the small animal department at the Lahr Animal Health Center. Susanne Arndt has been the owner of her own practice since 2013. She also holds a Master's degree in Small Animal Science from the Free University of Berlin, participates in ongoing professional development in the field of osteosynthesis, and is a member of the German Veterinary Medical Society, the Feline Medicine Working Group of the German Society for Veterinary Medicine and Veterinary Surgery (DGK-DVG), and the Laser Medicine Working Group of the DGK-DVG.

Important NOTE: This article is for general information purposes only. Whether chemotherapy is medically appropriate for a dog can only be decided after examination, a confirmed tumor diagnosis, and an individual benefit-risk assessment.